On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro-whole blood samples

scientific article

On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro-whole blood samples is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JPBA.2009.02.001
P698PubMed publication ID19269771
P5875ResearchGate publication ID24185301

P50authorJulien DéglonQ43198020
Aurélien ThomasQ43198023
Christian StaubQ115891333
Patrice ManginQ6066417
P2093author name stringAntonio Cataldo
P433issue4
P1104number of pages6
P304page(s)1034-1039
P577publication date2009-02-13
P1433published inJournal of Pharmaceutical and Biomedical AnalysisQ15752537
P1476titleOn-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro-whole blood samples
P478volume49

Reverse relations

cites work (P2860)
Q39816327A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry
Q57288446Analysis of insulin and insulin analogues from dried blood spots by means of LC-HRMS
Q33748874Critical Topics in Ensuring Data Quality in Bioanalytical LC–MS Method Development
Q38571074Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs.
Q51788759DBS direct elution: optimizing performance in high-throughput quantitative LC-MS/MS analysis.
Q90633011Determination of Antidepressants and Antipsychotics in Dried Blood Spots (DBSs) Collected from Post-Mortem Samples and Evaluation of the Stability over a Three-Month Period
Q82483202Development and Validation of an HPLC–MS/MS Method for The Analysis of Dexamethasone from Pig Synovial Fluid Using Dried Matrix Spotting
Q37894587Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications.
Q37859735Dried blood spots, pharmacokinetic studies and better medicines for children.
Q38201371Dried blood spots: concepts, present status, and future perspectives in bioanalysis
Q53394043Dried matrix spot direct analysis: evaluating the robustness of a direct elution technique for use in quantitative bioanalysis.
Q38201783Emerging liquid chromatography-mass spectrometry technologies improving dried blood spot analysis
Q39791872Evaluation of blood microsampling techniques and sampling sites for the analysis of drugs by HPLC-MS.
Q82482333Exploring the Feasibility of Using the DBS Technique for Metabolite Radioprofiling
Q42940917High-throughput phospholipidic fingerprinting by online desorption of dried spots and quadrupole-linear ion trap mass spectrometry: evaluation of atherosclerosis biomarkers in mouse plasma
Q82483135Increasing Efficiency for Dried Blood Spot Analysis: Prospects for Automation and Simplified Sample Analysis
Q87426856Investigation of endogenous blood lipids components that contribute to matrix effects in dried blood spot samples by liquid chromatography-tandem mass spectrometry
Q38810590Is there a role for microsampling in antibiotic pharmacokinetic studies?
Q37841718Microassay of drugs and modern measurement techniques
Q38153799Microsample analyses via DBS: challenges and opportunities.
Q38221657Multi-target screening of biological samples using LC-MS/MS: focus on chromatographic innovations
Q40167311Multiplexed extraction and quantitative analysis of pharmaceuticals from DBS samples using digital microfluidics
Q82483142Pharmacokinetic Considerations as to When to Use Dried Blood Spot Sampling
Q49584050Quantitation of Fentanyl Analogs in Dried Blood Spots by Flow-Through Desorption Coupled to Online Solid Phase Extraction Tandem Mass Spectrometry
Q53128171Rapid LC-MS/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment.
Q38003498Recent advances in column switching sample preparation in bioanalysis
Q47387427Semi-automated direct elution of dried blood spots for the quantitative determination of guanfacine in human blood
Q82483225Sensitive Determination of a Drug Candidate in Dried Blood Spots Using a TLC–MS Interface Integrated into a Column-Switching LC–MS/MS System
Q45854049Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer
Q38266512Spot them in the spot: analysis of abused substances using dried blood spots.
Q58805777The Use of Dried Blood Spots for the Quantification of Antihypertensive Drugs
Q38253959The use of mass spectrometry to analyze dried blood spots
Q38247481Therapeutic drug monitoring by dried blood spot: progress to date and future directions
Q42806889Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
Q42739574Use of dried blood spots in drug development: pharmacokinetic considerations
Q45998866Utilization of DBS Within Drug Discovery: Development of a Serial Microsampling Pharmacokinetic Study in Mice

Search more.